4507
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Shionogi & Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sales of prescription medicines. The company operates as a single business segment and focuses on therapeutic areas including infectious diseases, pain treatment, and metabolic diseases. Key products include the antibiotic Shiomarin, the hyperlipidemia treatment Crestor, and the anti-HIV agent Tivicay. The group structure includes subsidiaries such as Shionogi Pharma, Shionogi Healthcare, Shionogi Inc., Qpex Biopharma, Tetra Therapeutics, and ViiV Healthcare. Shionogi was founded in 1878 as a drug wholesaler and has since evolved into a manufacturer of proprietary antibiotics and other pharmaceuticals.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - General Homepage shionogi.com
Sector Healthcare IR page shionogi.com/global/en/investors.html
Tags
antibiotics, anti-hiv, hyperlipidemia, pain treatment, infectious diseases, metabolic diseases, prescription medicines, Shionogi Pharma, Shionogi Healthcare, Shionogi Techno Advance Research, Torii Pharmaceutical, Shionogi Business Partner, Shionogi Inc., Qpex Biopharma, Tetra Therapeutics, Shionogi-Apnimed Sleep Science, Shionogi B.V., ViiV Healthcare, Shinomin, Shiomarin, Crestor, Tivicay
Press page shionogi.com/global/en/news

Metrics

Valuation  
Market cap ¥ 2.525T
Market cap (USD) $ 15.852B
P/E 10.02
PEG 2.85
P/BV 1.45
P/S 5.05
P/OCF 11.82
P/FCF 12.68
Dividend yield 2.5%
Turnover / mcap —
Returns  
ROE 13.5%
ROI 12.2%
ROIC 8.5%
Profit margin 41.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 3.5%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 39
Quality score 33.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 499.677B 438.268B 410.073B 426.684B 335.138B 297.177B 333.371B 363.721B 344.667B 338.89B 309.973B 273.991B 289.717B 282.903B
Net profit 205.159B 170.435B 162.03B 184.965B 114.185B 111.858B 122.193B 132.759B 108.866B 83.879B 66.687B 44.06B 40.618B 66.727B
Free cash flow 199.108B 143.357B 126.017B 140.68B 70.504B 80.857B 120.172B 136.56B 112.778B 88.644B 87.19B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.472K 2.244K 7.767K 5.976K 7.526K 5.952K 5.307K 6.852K 5.491K 5.748K 5.301K 4.005K 1.913K 1.943K
Price performance 12m 0.55 -0.71 0.3 -0.21 0.26 0.12 -0.23 0.25 -0.04 0.08 0.32 1.09 -0.02 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 59.3B 53.2B 101B 79.8B 78B 123B 110B 123B 121B 160B
↳ YoY growth -9.0% -10.3% -20.9% -2.2% +57.6% -10.7% +11.9% -1.9% +32.5%
↳ 5y CAGR +4.0% +8.6% +15.4%
Borrowings, current (JPY) — 10B 918M — — — — — — 660B
Borrowings, non-current (JPY) 30.1B 18.5B — — — — — — — —
Bonds payable (JPY) 20.1B 18.5B 920M — — — — — — —
Lease liabilities (JPY) — — 9.31B 8.15B 7.99B 6.67B 9.41B 11.6B 21.9B 24.4B
Cash and deposits (JPY) 108B 140B 196B 209B 276B 254B 309B 358B 375B 711B
Intangible assets (JPY) 91.1B 75.1B 47.8B 46.5B 76.6B 81.2B 96.3B 118B 144B 174B
Right-of-use assets (JPY) — — 5.92B 4.66B 4.83B 3.52B 6.48B 9.44B 19.4B 22.8B
Net debt (borrowings + leases - cash) (JPY) -77.8B -112B -186B — — — — — — -27B
Cash flow detail
Operating cash flow (JPY) 112B 130B 165B 132B 109B 102B 178B 154B 195B 214B
Purchases of property, plant and equipment (JPY) -10.4B -5.88B -6.55B -8.95B -28.2B -26.2B -11.9B -12.7B -17.1B -14.5B
Purchases of intangible assets (JPY) -12.8B -11.1B -18.8B -2.82B -4.76B -5.38B -25.3B -15.6B -35B -16.8B
Change in receivables (cash effect) (JPY) 5.8B 5.97B -18.6B 21.4B 2.99B -43.4B 13.9B -12.4B 1.91B -2.58B
Change in inventories (cash effect) (JPY) 625M 6.55B -3.64B 1.16B -3.44B -7.13B -11.7B -6.34B -388M -12.7B
Change in payables (cash effect) (JPY) 893M -3.81B 4.92B -5.75B -2.38B 11.7B 7.74B -5.82B -1.7B 7.03B
Dividends paid (cash effect) (JPY) -22.1B -24.2B -27.6B -31.1B -32.5B -33.1B -36.1B -43.9B -48.7B -56.2B
Share buybacks (cash effect) (JPY) -35B -29.4B -50.3B -50.2B -50.1B -14M -49.5B -75.2B -10M -5M
Interest paid (cash effect) (JPY) -207M -545M -693M -348M -256M -87M -94M -164M -305M -344M
Income taxes paid (cash effect) (JPY) -34B -38.6B -23.7B — — -39.3B -27.3B — — —
Operating cash flow before change in receivables (JPY) 106B 124B 184B 111B 106B 145B 164B 167B 194B 216B
Free cash flow (OCF - PPE - intangibles) (JPY) 88.6B 113B 140B 120B 76.1B 70.5B 141B 126B 143B 182B
Income detail
Research and development expense (JPY) 59.9B 59.9B 52.1B 47.9B 54.2B 73B 102B 103B 109B 123B
↳ 5y CAGR +14.5% +17.8% +17.8%
Total comprehensive income (JPY) 69.4B 131B 137B 36.4B 138B 162B 209B 254B 171B 380B
Comprehensive income to owners (JPY) 70B 131B 138B 36.6B 137B 162B 209B 255B 171B 379B
Reported Jun 22, 2017 Jun 20, 2018 Jun 24, 2020 Jun 24, 2020 Jun 23, 2021 Jun 22, 2023 Jun 22, 2023 Jun 21, 2024 Jun 19, 2025 Jun 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

IntraBio社の買収完了について Bull 3 Bear 0 M&A

Prompts

Shionogi & Co., Ltd. (ticker 4507), listed in Japan.

Company History

Date Change Detail
Jul 10, 2025 Acquired Acquired Torii Pharmaceutical Co., Ltd. (EDINET code E00934). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding Shionogi & Co., Ltd.

ETF Weight in ETF Shares Market value As of
JPAN 1.12% 6,500 $ 111.543K Jun 30, 2026
RFDI 0.37% 33,400 $ 610.565K Jul 31, 2026
AVIV 0.25% 258,600 $ 5.166M Nov 16, 2026
JHID 0.24% 1,540 $ 26.427K Jun 30, 2026
AVSD 0.11% 21,000 $ 419.521K Nov 16, 2026
JSTC 0.09% 13,320 $ 270.281K Nov 17, 2026
DFIV 0.08% 864,000 $ 16.956M Nov 12, 2026
DFAI 0.07% 629,700 $ 12.358M Nov 12, 2026
DFIC 0.05% 379,300 $ 7.444M Nov 12, 2026
AVDE 0.04% 356,700 $ 7.126M Nov 16, 2026
DXIV 0.04% 4,800 $ 94.199K Nov 12, 2026
DFSI 0.04% 21,400 $ 419.97K Nov 12, 2026
DFAX 0.02% 148,600 $ 2.916M Nov 12, 2026